Early recurrence patterns after neoadjuvant chemoradiotherapy and chemoimmunotherapy in esophageal squamous cell carcinoma: A multicenter study

Clicks: 29
ID: 328296
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #26 of 49 articles by views in european journal of cardio-thoracic surgery : official journal of the european association for cardio-thoracic surgery

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
OBJECTIVE: To compare early recurrence patterns and survival outcomes between neoadjuvant chemoimmunotherapy (NCIT) and neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: This retrospective cohort study included 1428 patients with stage IIB-IVA ESCC who underwent NCIT or NCRT followed by radical surgery. Outcomes included overall survival (OS), recurrence-free survival (RFS), locoregional recurrence, distant metastasis, and post-recurrence survival (PRS). Propensity score matching (1:1 ratio, 0.1 caliper; balance threshold: standardized mean difference <0.10) and multivariable Cox regression were utilized. RESULTS: After propensity score matching (532 patients per group), the NCIT group exhibited better 3-year OS (72.2% vs 60.9%; hazard ratio [HR], 0.69; 95% confidence interval [CI], 0.56-0.85; P < .001) and RFS (67.8% vs. 59.3%; HR, 0.70; 95% CI, 0.57-0.86; P < .001) than the NCRT group. The NCIT group also had lower rates of early overall recurrence (131 [24.6%] vs. 196 [36.8%]; P < .001) and early distant metastasis (73 [13.7%] vs. 125 [23.5%]; P < .001) than the NCRT group. Multivariable regression analysis identified NCRT (vs NCIT), higher ypN stage, and not achieving a major pathological response as independent risk factors for both early overall recurrence and early distant metastasis. Among patients who experienced early recurrence, PRS did not differ between the two modalities (HR, 0.81; 95% CI, 0.63-1.04; P = .086). Although the NCRT group had a higher major pathological response rate, NCIT was associated with better early recurrence control even among patients achieving major pathological response (HR, 0.61; 95% CI, 0.47-0.84; P < .001). CONCLUSIONS: Compared with NCRT, NCIT is associated with a lower incidence of early recurrence, particularly distant metastasis, which may contribute to the observed OS advantage. The poor prognosis after early recurrence highlights the need for intensified postoperative surveillance in high-risk patients.
Reference Key
openalex_W7212063817 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cien Sun, Chunji Chen, Hua Sun, Hao Liu, Qianyi Chen, Zimin Wang, Jiawen Chen, William C Cho, Zhigang Li, Zhichao Liu, Dehua Ma, Minhua Ye, Chunguo Wang, Qinya Wang, Xuefeng Leng, Yongtao Han, Qifeng Wang, Jiahua Lv, Hainan Chen, Jinbo Zhao, Xiaolong Yan, Huilai Lv, Ziqiang Tian, Changchun Wang, Liwei Xu, Youhua Jiang, Zhengyang Zhang, Q. Zhong, Jiangbo Lin, Xinyu Mei, Xiaoyang Li, Dong Qian, Chengchu Zhu, Xufeng Guo, Jianfei Shen
Journal european journal of cardio-thoracic surgery : official journal of the european association for cardio-thoracic surgery
Year 2026
DOI
10.1093/ejcts/ezag219
URL
https://academic.oup.com/ejcts/advance-article-pdf/doi/10.1093/ejcts/ezag219/71000585/ezag219.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.